Vaughn Himes
Director/Board Member chez ACHIEVE LIFE SCIENCES, INC.
Fortune : - $ au 31/03/2024
Profil
Actuellement, Vaughn B. Himes occupe le poste de directeur technique chez Seagen Inc. Au cours de sa carrière antérieure, il a été vice-président principal des opérations techniques chez ZymoGenetics, Inc, vice-président des opérations de fabrication chez AmpliPhi Biosciences Corp, vice-président de la fabrication mondiale chez Corixa Corp, vice-président du développement des produits chez Genovo, Inc et directeur associé du développement biologique chez Wyeth Lederle Vaccines SA. Vaughn B. Himes a obtenu un diplôme de premier cycle au Pomona College et un doctorat à l'université du Minnesota.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
22/01/2024 | 0 ( -.--% ) | - $ | 31/03/2024 | |
VBI VACCINES, INC.
-.--% | 27/07/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Vaughn Himes
Sociétés | Poste | Début |
---|---|---|
ACHIEVE LIFE SCIENCES, INC. | Director/Board Member | 14/03/2022 |
VBI VACCINES INC. | Director/Board Member | 24/04/2023 |
Anciens postes connus de Vaughn Himes
Sociétés | Poste | Fin |
---|---|---|
SEAGEN INC. | Chief Operating Officer | 01/07/2012 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Chief Tech/Sci/R&D Officer | 01/03/2009 |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Corporate Officer/Principal | 01/10/2005 |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/03/2003 |
Genovo, Inc.
Genovo, Inc. Medical SpecialtiesHealth Technology Part of Innoviva, Inc., Genovo, Inc. is a maker of gene and cell therapy products. The private company is based in Sharon Hill, PA. Genovo was acquired by AmpliPhi Biosciences Corp. on September 20, 2000 for $84.53 million. | Corporate Officer/Principal | 01/01/2000 |
Formation de Vaughn Himes
Pomona College | Undergraduate Degree |
University of Minnesota | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
VBI VACCINES INC. | Health Technology |
ACHIEVE LIFE SCIENCES, INC. | Health Technology |
Entreprise privées | 6 |
---|---|
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Health Technology |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Health Technology |
Seagen Inc.
Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
Genovo, Inc.
Genovo, Inc. Medical SpecialtiesHealth Technology Part of Innoviva, Inc., Genovo, Inc. is a maker of gene and cell therapy products. The private company is based in Sharon Hill, PA. Genovo was acquired by AmpliPhi Biosciences Corp. on September 20, 2000 for $84.53 million. | Health Technology |
Wyeth Lederle Vaccines SA
Wyeth Lederle Vaccines SA Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Wyeth Lederle Vaccines SA develops and manufactures pharmaceutical products. The private company is based in Louvain-la-Neuve, Belgium. | Health Technology |